- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | - | SGX Company Announcements | ||
| 11.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: WAIVER::WAIVER ANNOUNCEMENT | 8 | SGX Company Announcements | ||
| TIANJIN PHARMACEUTICAL DA REN TANG Aktie jetzt für 0€ handeln | |||||
| 05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::INCREASE IN S-SHARES BY CONTROLLING SHAREHOLDER | 1 | SGX Company Announcements | ||
| 05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::INCREASE IN S-SHARES BY CONTROLLING SHAREHOLDER | 3 | SGX Company Announcements | ||
| 05.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::INCREASE IN S-SHARES BY CONTROLLING SHAREHOLDER AND PROPOSED SHAREHOLDING INCREASE PLAN | 2 | SGX Company Announcements | ||
| 02.02. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::CASH DIVIDEND/DISTRIBUTION::MANDATORY | - | SGX Company Announcements | ||
| 30.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 2 | SGX Company Announcements | ||
| 28.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::ANNOUNCEMENT OF APPOINTMENT | 2 | SGX Company Announcements | ||
| 23.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CASH DIVIDEND/DISTRIBUTION::MANDATORY | 6 | SGX Company Announcements | ||
| 12.01. | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE 2ND EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2025 HELD ON 15 DECEMBER 2025 | 1 | SGX Company Announcements | ||
| 31.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDATE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 15.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::ANNOUNCEMENT OF CESSATION | 1 | SGX Company Announcements | ||
| 15.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 09.12.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 28.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: REPL::EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| 28.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY | 1 | SGX Company Announcements | ||
| 25.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON RECEIPT OF DRUG REGISTRATION CERTIFICATE | - | SGX Company Announcements | ||
| 24.11.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE | 1 | SGX Company Announcements | ||
| 30.10.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: EXTRAORDINARY/SPECIAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 30.10.25 | TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED: GENERAL ANNOUNCEMENT::AMENDMENTS TO THE ARTICLES OF ASSOCIATION OF THE COMPANY | - | SGX Company Announcements |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRAZENECA | 177,25 | +0,45 % | UBS stuft ASTRAZENECA auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Astrazeneca von 16300 auf 17600 Pence angehoben und die Einstufung auf "Buy" belassen. Astrazeneca stehe zum Ende dieses Jahrzehnts... ► Artikel lesen | |
| TEVA | 28,100 | -2,09 % | Teva Pharmaceutical Industries Ltd: Teva to Present at the Upcoming Investor Conferences in March | PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will... ► Artikel lesen | |
| SINOPHARM | 2,289 | +0,93 % | HSI Closes at 26,765, Up 175 pts; HSTI Closes at 5,260, Down 10 pts; HAIDILAO Up over 6%; HSBC HOLDINGS, TINGYI, SINOPHARM, TIME INTERCON, WANGUO GOLD GP Hit New Highs; Market Turnover Rises | ||
| CSPC PHARMA | 1,078 | +1,27 % | CSPC PHARMA (01093): CONNECTED TRANSACTION - DISPOSAL OF 30.0704% EQUITY INTEREST IN THE TARGET COMPANY | ||
| WUXI BIOLOGICS | 4,389 | +1,06 % | CLSA Favors CDMOs for Earnings Visibility, Top Picks WUXI APPTEC/WUXI BIO/PHARMARON | ||
| OPKO HEALTH | 1,020 | 0,00 % | OPKO Health, Inc.: OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results | MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,122 | -2,12 % | FOSUN PHARMA (02196): POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING, THE 2026 FIRST A SHAREHOLDERS' CLASS ... | ||
| GEDEON RICHTER | 31,380 | 0,00 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 12,500 | 0,00 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| THC BIOMED | 0,011 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 23.09.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.09.2025.ISIN NameAU0000221251 LEO... ► Artikel lesen | |
| BAYER | 42,010 | +0,39 % | Märkte am Morgen: Bayer, SAP, Scout24, Knorr-Bremse, thyssenkrupp, Bitcoin | Der DAX hat eine turbulente Woche hinter sich. Am Freitag gab es noch einmal einen ordentlichen Schub nach oben. In den USA hatte der Supreme Court die Zölle von Donald Trump für unrechtmäßig erklärt.... ► Artikel lesen | |
| MERCK KGAA | 127,75 | +1,67 % | Big Blue IBM, Fastly & Merck KGaA - Was sagen Charts UND Fundamentaldaten wirklich? | ||
| NOVO NORDISK | 31,600 | -0,24 % | Opening Bell: Coca-Cola, Nvidia, Eli Lilly, Novo Nordisk, Vistra Energy, Energy Fuels | An der Wall Street richtet sich die Aufmerksamkeit mal wieder auf die Zollpolitik von Donald Trump. Der Supreme Court hatte am Freitag die bisherigen Maßnahmen gekippt. Trump mit neuen Zöllen unter... ► Artikel lesen | |
| SANOFI | 81,41 | -0,40 % | Regeneron und Sanofi erhalten Empfehlung für erweiterte Dupixent-Zulassung | DJ Regeneron und Sanofi erhalten Empfehlung für erweiterte Dupixent-Zulassung
Von Colin Kellaher
DOW JONES--Der Ausschuss für Humanarzneimittel (CHMP) der Europäischen Arzneimittel-Agentur... ► Artikel lesen | |
| PFIZER | 23,350 | -0,17 % | Pfizer, Astellas Pharma Share Positive Data From Bladder Cancer Trial | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and Astellas Pharma Inc., Friday announced the positive results from the Phase 3 EV-304 clinical trial for PADCEV in combination with Keytruda in... ► Artikel lesen |
Das Unternehmen TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,050 (+1,71 %) liegt der Kurs bei 2,967 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORP LTD finden Sie auf Wallstreet Online.